Last reviewed · How we verify
standard statin therapy
standard statin therapy is a Small molecule drug developed by Beijing Anzhen Hospital. It is currently FDA-approved.
Standard statin therapy is a small molecule intervention used to treat various conditions, including chronic nephropathy, proteinuria, hypertension, foot ulcers, and arteriosclerosis obliterans. Statins, such as fluvastatin, are added to existing treatments like ACE-inhibitors and angiotensin receptor antagonists to manage these conditions.
At a glance
| Generic name | standard statin therapy |
|---|---|
| Sponsor | Beijing Anzhen Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer (PHASE1, PHASE2)
- Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease (NA)
- Chaigui Longmu Ejiao Paste for Ischemic Heart Disease (PHASE2)
- Optimizing Non-statin Agents for ASCVD
- Focusing on the Menopausal Transition to Improve Mid-Life Women's Health (PHASE2, PHASE3)
- Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes (PHASE3)
- Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
- Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- standard statin therapy CI brief — competitive landscape report
- standard statin therapy updates RSS · CI watch RSS
- Beijing Anzhen Hospital portfolio CI
Frequently asked questions about standard statin therapy
What is standard statin therapy?
Who makes standard statin therapy?
What development phase is standard statin therapy in?
Related
- Manufacturer: Beijing Anzhen Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing